AIBIOS Funding & Investors
AIBIOS has designed and developed a series of novel small molecules which modulate both the innate (macrophages) and adaptive immune system to treat therapeutic indications of Gastroenterology, Respiratory, and Neurological diseases.
aibios.comTotal Amount Raised: $7,862,328
AIBIOS Funding Rounds
Seed
4,608,029 JPY
Seed Investors
SBI Investment Co.Seed
3,254,299 JPY
Funding info provided by Diffbot.